申请人:Li Renhua
公开号:US20090099182A1
公开(公告)日:2009-04-16
The present invention discloses novel compounds of Formula I:
having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
本发明披露了一种新的I式化合物:具有11β-HSD类型1拮抗剂活性的化合物,以及制备这种化合物的方法。在另一实施例中,该发明还披露了包含I式化合物的制药组合物,以及使用该化合物和组合物治疗糖尿病、高血糖、肥胖症、高血压、高脂血症、代谢综合征和其他与11β-HSD类型1活性有关的疾病的方法。